Formation Pediatrie

Diplôme Universitaire "Hypnothérapie"

Objectifs

 

Acquérir une formation complète et de qualité à la pratique de l’hypnose, particulièrement dans le domaine de la psychothérapie (hypnothérapie) Apporter aux praticiens des connaissances scientifiques précises sur les phénomènes mis en jeu en hypnose et ses modalités d’action Transmettre des compétences dévaluation et de modalité d’intervention hypnothérapeutique selon le type de trouble présenté  

 

Programme

 

MODULE 1 - 28h


1- Technique et méthode hypnotique 2- De la recherche à la clinique

MODULE 2 - 14h 


1- La dépendance 2- Les addictions

MODULE 3 - 14h


1- Les troubles anxieux 
2- la perte et la dépression

MODULE 4 - 14h


1- La psychosomatique 
2- Etats dissociatifs

MODULE 5 - 14h


1- Douleur aiguë
 2- Douleur chronique

MODULE 6 - 14h


1-Le trans-générationnel 
2- La sexothérapie


MODULE 7 - 21h


Etudes de cas / Supervision


MODULE 8 - 7h 


Conférenciers invités


MODULE 9- 14h 


1- Mémoire 
2- Soutenance théorico-clinique

 


Pour bien mincir, il faut sortir du diktat des régimes

VIDÉO - Pour sa grande première, la nouvelle émission santé du Figaro Live aborde la question des régimes avec le médecin nutritionniste Jean-Michel Lecerf. Vous pouvez revoir l?émission en replay.

Joint EFGCP / DIA / EMA Medicines for Children Conference onDevelopment of Paediatric Medicines: From Learning to Adapting

Editorial

The EU paediatric regulation has now been in force since 2007 and has considerably changed the place of paediatric drug development in the general drug development process. Drug development is no longer possible without considering children. The aim of this conference is to discuss on a high level where we stand with paediatric drug development in Europe, where the partners in drug development, i.e. clinicians, industry, regulators and others, agree and where they disagree, in which area the EU regulation can be considered a success, where the regulation might be modified in the future, where and how its daily interpretation by the EMA will be modified, and where collaboration between the involved players can be improved.

The EFGCP / DIA / EMA Paediatric Conference allows an open discussion between academics, clinicians, regulatory authorities, parents’ & patients’ associations and pharmaceutical industry about paediatric drug development. The conference is an annual event that goes back to two series of annual conferences: a first one initiated in 2005 by EFGCP, and a second one initiated in 2007 by DIA. Both were organised in tight collaboration with the EMEA, which in 2011 changed its name to EMA. Since 2010 the two conference series have been merged, and since 2011 EMA is officially co-producing the conference as an equal partner.

The EU paediatric regulation has transformed paediatric drug development from a topic discussed by a handful of interested paediatricians, clinical pharmacologists and regulators to an issue that is broadly known within pharmaceutical industry, regulatory authorities, the clinical world and other institutions. More than 1000 PIPs have so far been submitted, and virtually everybody within pharmaceutical industry has heard of the PIP requirement.

The level of detail in the key elements of Paediatric Investigation Plan has been continuously discussed since the Paediatric Regulation came into force. In the 2011 conference, EMA announced that changes will come in this area; this year EMA will announce how these changes will look like.

As in previous conferences, representatives from all stakeholders will give presentations, and on day 1, participants will have the choice between three breakout sessions to discuss specific issues in smaller groups. This will allow participants to exchange on eye level and face-to-face with their respective counterparts who otherwise interact predominantly by phone and only occasionally at face-to-face meetings.


 


Implant Essure : pour le comité d?experts, inutile de changer la règlementation

Pour les huit experts réunis par l?Agence du médicament chargés d?en évaluer les risques, la balance bénéfice/risques de l?implant de stérilisation est favorable.

DIU Douleur de l'enfant en pratique quotidienne

Editorial

Co-organisation par les unités douleur des hôpitaux Armand Trousseau et Bicêtre

Formation sur 1 an, avec :

12 journées de formation (96 heures d’enseignement) Des ateliers pratiques 5 journées de formation pratique : stage au sein d’unités douleur pédiatriques 2 journées de présentation des projets professionnels de chaque étudiant Validation : contrôle continu des connaissances, assiduité, réalisation d’un projet professionnel sur la douleur de l’enfant.

Objectifs

acquérir les notions indispensables pour reconnaître et traiter la douleur des enfants 

Programme

http://www.pediadol.org/DIU-La-douleur-de-l-enfant-en.html
 

Intervenants

Comité d'organisation

Comité scientifique

unités douleur des hôpitaux Armand Trousseau et Bicêtre

Dr Fournier-Charrière, Dr Annequin, Dr Tourniaire, Mme Lombart


Testez vos connaissances sur les présidents de la République et la santé

QUIZ - La santé et les présidents de la République française? Une longue histoire ! Que ce soit la leur ou des décisions impactant celle de leurs concitoyens, la santé a toujours été un sujet majeur dans l?Histoire de nos Républiques. Faites notre quiz !

12th International Congress of Pediatric Pulmonology - CIPP

Editorial

Is the only global meeting that is fully dedicated to pediatric pulmonology.
 

Objectifs

The 12th CIPP has also endeavored to increase its educational activities    

Programme

http://www.cipp-meeting.org/program_day.htm


Un test sanguin pour diagnostiquer les bébés secoués

Des chercheurs américains ont mis au point un test sanguin capable de détecter les cas d?hémorragies intracrâniennes chez les bébés secoués. Les analyses se poursuivent avant une éventuelle mise sur le marché.

Copedia

Editorial

 

Dear Colleagues,

It is my great honor and pleasure to invite you to participate at the World Congress on Controversies in Pediatrics (CoPEDIA) will take place in Prague, Czech Republic, April 24-27, 2014.

CoPEDIAis a concept congress dealing mainly with controversial issues in the format of debates and discussions allowing ample time for speaker-participant interaction.

The ability to discuss controversial topics with emphasis on clinical solutions in cases where no agreed-upon answers exist provides clinicians with an insight and a take-home message that ameliorates treatment in the most difficult situations.

I very much hope that you will be able to accept my invitation and make an important contribution to the success of this Congress.

I look forward to your participation and contribution.

Prof. Ami Ballin


Speakers

Organizing committee

JIRI BRONSKY, CZECH REPUBLIC
Paediatric Gastroenterology, University Hospital Motol, PragueTAADEJ AVCIN, SLOVENIA
Department of Allergology, Rheumatology and Clinical Immunology University Children's Hospital University Medical Center LjubljanaANTHONY CHAN, CANADA
McMaster University, Department of Pediatrics, Division of Hematology/Oncology, HamiltonCHRISTOPHE DUPONT, FRANCE
Head of the Pediatrics-Gastroenterology Department at the Necker Hospital in ParisGILI KENET
Director, Pediatric Coagulation Service, The National Hemophilia Center, Tel-HashomerSheba Medical Center, Tel-HashomerTHOMAS KUHNE, SWITZERLAND
Professor of pediatric Oncology/Hematology, University Children's Hospital BaselANGELO CLAUDIO MOLINARI, ITALY
Dept. of Hematology and Oncology Head, Thrombosis and Hemostasis Unit, Giannina Gaslini Children's Hospital, GenoaHANIA SZAJEWSKA, POLAND 
Department of Paediatrics, The Medical University of WarsawVITTORIO PENGO, ITALY
Clinica Cardiologica, Centro Trombosi,Dipartmento di Scienze Cardiologiche Toraciche e Vascolari, Università degli Studi di PadovaRICHARD RUSSELL, SCOTLAND
Consultant Paediatric Gastroenterologist Yorkhill Hospital, GlasgowRICCARDO TRONCONE, ITALY
Head of the European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, NaplesJARON RABINOVICI, ISRAEL
Department of gynecology and obstetrics, Sheba Medical Center, Tel HashomerCH VAN OMMEN, THE NETHERLANDS
Department of Pediatric Hematology Emma Children's Hospital AMC, AmsterdamDAVID C. WILSON, UK
Paediatric Gastroenterology and Nutrition, Child Life and Health, College of Medicine and Veterinary Medicine, University of Edinburgh
 


Dépakine: entre 2000 et 4000 enfants nés mal formés

L?Assurance-maladie et l?agence du médicament ont chiffré le nombre de malformations congénitales liées à l?antiépileptique.

Congres Genetique

Dentaires Soins

Congres Orthophonie

Congres Homeopathie

Formation Implantologie

Formation Pediatrie

Formation Pediatrie

Diplôme Universitaire "Hypnothérapie"

Objectifs

 

Acquérir une formation complète et de qualité à la pratique de l’hypnose, particulièrement dans le domaine de la psychothérapie (hypnothérapie) Apporter aux praticiens des connaissances scientifiques précises sur les phénomènes mis en jeu en hypnose et ses modalités d’action Transmettre des compétences dévaluation et de modalité d’intervention hypnothérapeutique selon le type de trouble présenté  

 

Programme

 

MODULE 1 - 28h


1- Technique et méthode hypnotique 2- De la recherche à la clinique

MODULE 2 - 14h 


1- La dépendance 2- Les addictions

MODULE 3 - 14h


1- Les troubles anxieux 
2- la perte et la dépression

MODULE 4 - 14h


1- La psychosomatique 
2- Etats dissociatifs

MODULE 5 - 14h


1- Douleur aiguë
 2- Douleur chronique

MODULE 6 - 14h


1-Le trans-générationnel 
2- La sexothérapie


MODULE 7 - 21h


Etudes de cas / Supervision


MODULE 8 - 7h 


Conférenciers invités


MODULE 9- 14h 


1- Mémoire 
2- Soutenance théorico-clinique

 


Pour bien mincir, il faut sortir du diktat des régimes

VIDÉO - Pour sa grande première, la nouvelle émission santé du Figaro Live aborde la question des régimes avec le médecin nutritionniste Jean-Michel Lecerf. Vous pouvez revoir l?émission en replay.

Joint EFGCP / DIA / EMA Medicines for Children Conference onDevelopment of Paediatric Medicines: From Learning to Adapting

Editorial

The EU paediatric regulation has now been in force since 2007 and has considerably changed the place of paediatric drug development in the general drug development process. Drug development is no longer possible without considering children. The aim of this conference is to discuss on a high level where we stand with paediatric drug development in Europe, where the partners in drug development, i.e. clinicians, industry, regulators and others, agree and where they disagree, in which area the EU regulation can be considered a success, where the regulation might be modified in the future, where and how its daily interpretation by the EMA will be modified, and where collaboration between the involved players can be improved.

The EFGCP / DIA / EMA Paediatric Conference allows an open discussion between academics, clinicians, regulatory authorities, parents’ & patients’ associations and pharmaceutical industry about paediatric drug development. The conference is an annual event that goes back to two series of annual conferences: a first one initiated in 2005 by EFGCP, and a second one initiated in 2007 by DIA. Both were organised in tight collaboration with the EMEA, which in 2011 changed its name to EMA. Since 2010 the two conference series have been merged, and since 2011 EMA is officially co-producing the conference as an equal partner.

The EU paediatric regulation has transformed paediatric drug development from a topic discussed by a handful of interested paediatricians, clinical pharmacologists and regulators to an issue that is broadly known within pharmaceutical industry, regulatory authorities, the clinical world and other institutions. More than 1000 PIPs have so far been submitted, and virtually everybody within pharmaceutical industry has heard of the PIP requirement.

The level of detail in the key elements of Paediatric Investigation Plan has been continuously discussed since the Paediatric Regulation came into force. In the 2011 conference, EMA announced that changes will come in this area; this year EMA will announce how these changes will look like.

As in previous conferences, representatives from all stakeholders will give presentations, and on day 1, participants will have the choice between three breakout sessions to discuss specific issues in smaller groups. This will allow participants to exchange on eye level and face-to-face with their respective counterparts who otherwise interact predominantly by phone and only occasionally at face-to-face meetings.


 


Implant Essure : pour le comité d?experts, inutile de changer la règlementation

Pour les huit experts réunis par l?Agence du médicament chargés d?en évaluer les risques, la balance bénéfice/risques de l?implant de stérilisation est favorable.

DIU Douleur de l'enfant en pratique quotidienne

Editorial

Co-organisation par les unités douleur des hôpitaux Armand Trousseau et Bicêtre

Formation sur 1 an, avec :

12 journées de formation (96 heures d’enseignement) Des ateliers pratiques 5 journées de formation pratique : stage au sein d’unités douleur pédiatriques 2 journées de présentation des projets professionnels de chaque étudiant Validation : contrôle continu des connaissances, assiduité, réalisation d’un projet professionnel sur la douleur de l’enfant.

Objectifs

acquérir les notions indispensables pour reconnaître et traiter la douleur des enfants 

Programme

http://www.pediadol.org/DIU-La-douleur-de-l-enfant-en.html
 

Intervenants

Comité d'organisation

Comité scientifique

unités douleur des hôpitaux Armand Trousseau et Bicêtre

Dr Fournier-Charrière, Dr Annequin, Dr Tourniaire, Mme Lombart


Testez vos connaissances sur les présidents de la République et la santé

QUIZ - La santé et les présidents de la République française? Une longue histoire ! Que ce soit la leur ou des décisions impactant celle de leurs concitoyens, la santé a toujours été un sujet majeur dans l?Histoire de nos Républiques. Faites notre quiz !

12th International Congress of Pediatric Pulmonology - CIPP

Editorial

Is the only global meeting that is fully dedicated to pediatric pulmonology.
 

Objectifs

The 12th CIPP has also endeavored to increase its educational activities    

Programme

http://www.cipp-meeting.org/program_day.htm


Un test sanguin pour diagnostiquer les bébés secoués

Des chercheurs américains ont mis au point un test sanguin capable de détecter les cas d?hémorragies intracrâniennes chez les bébés secoués. Les analyses se poursuivent avant une éventuelle mise sur le marché.

Copedia

Editorial

 

Dear Colleagues,

It is my great honor and pleasure to invite you to participate at the World Congress on Controversies in Pediatrics (CoPEDIA) will take place in Prague, Czech Republic, April 24-27, 2014.

CoPEDIAis a concept congress dealing mainly with controversial issues in the format of debates and discussions allowing ample time for speaker-participant interaction.

The ability to discuss controversial topics with emphasis on clinical solutions in cases where no agreed-upon answers exist provides clinicians with an insight and a take-home message that ameliorates treatment in the most difficult situations.

I very much hope that you will be able to accept my invitation and make an important contribution to the success of this Congress.

I look forward to your participation and contribution.

Prof. Ami Ballin


Speakers

Organizing committee

JIRI BRONSKY, CZECH REPUBLIC
Paediatric Gastroenterology, University Hospital Motol, PragueTAADEJ AVCIN, SLOVENIA
Department of Allergology, Rheumatology and Clinical Immunology University Children's Hospital University Medical Center LjubljanaANTHONY CHAN, CANADA
McMaster University, Department of Pediatrics, Division of Hematology/Oncology, HamiltonCHRISTOPHE DUPONT, FRANCE
Head of the Pediatrics-Gastroenterology Department at the Necker Hospital in ParisGILI KENET
Director, Pediatric Coagulation Service, The National Hemophilia Center, Tel-HashomerSheba Medical Center, Tel-HashomerTHOMAS KUHNE, SWITZERLAND
Professor of pediatric Oncology/Hematology, University Children's Hospital BaselANGELO CLAUDIO MOLINARI, ITALY
Dept. of Hematology and Oncology Head, Thrombosis and Hemostasis Unit, Giannina Gaslini Children's Hospital, GenoaHANIA SZAJEWSKA, POLAND 
Department of Paediatrics, The Medical University of WarsawVITTORIO PENGO, ITALY
Clinica Cardiologica, Centro Trombosi,Dipartmento di Scienze Cardiologiche Toraciche e Vascolari, Università degli Studi di PadovaRICHARD RUSSELL, SCOTLAND
Consultant Paediatric Gastroenterologist Yorkhill Hospital, GlasgowRICCARDO TRONCONE, ITALY
Head of the European Laboratory for the Investigation of Food-Induced Diseases, University Federico II, NaplesJARON RABINOVICI, ISRAEL
Department of gynecology and obstetrics, Sheba Medical Center, Tel HashomerCH VAN OMMEN, THE NETHERLANDS
Department of Pediatric Hematology Emma Children's Hospital AMC, AmsterdamDAVID C. WILSON, UK
Paediatric Gastroenterology and Nutrition, Child Life and Health, College of Medicine and Veterinary Medicine, University of Edinburgh
 


Dépakine: entre 2000 et 4000 enfants nés mal formés

L?Assurance-maladie et l?agence du médicament ont chiffré le nombre de malformations congénitales liées à l?antiépileptique.

Congres Genetique

Dentaires Soins

Congres Orthophonie

Congres Homeopathie

Formation Implantologie